Loïc Mathieu

Title: Loïc Mathieu: Innovator in Azaindole Derivatives

Introduction

Loïc Mathieu is a notable inventor based in Lyons, France. He has made significant contributions to the field of medicinal chemistry, particularly through his work on azaindole derivatives. With a total of 2 patents, his innovations focus on compounds that serve as inhibitors of ERK kinase activity.

Latest Patents

Among his latest patents, one notable invention is related to azaindole derivatives and their use as ERK kinase inhibitors. The present invention concerns a compound of formula (I) or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity, in particular ERK2 activity. This work highlights the potential therapeutic applications of these compounds in treating various diseases.

Career Highlights

Loïc Mathieu has worked with prominent organizations such as Agv Discovery and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Loïc has collaborated with esteemed colleagues, including Cédric Bories and Muriel Gelin. These partnerships have enriched his research and fostered innovation in his field.

Conclusion

Loïc Mathieu's work in developing azaindole derivatives showcases his commitment to advancing medicinal chemistry. His contributions through patents and collaborations reflect his significant role in the scientific community.